Meyer Alexander, Horch Raymund E, Schoengart Elisabeth, Beier Justus P, Taeger Christian D, Arkudas Andreas, Lang Werner
Department of Vascular Surgery, University Hospital Erlangen, Krankenhausstrasse 12, 91054 Erlangen, Germany.
Department of Plastic and Hand Surgery, University Hospital Erlangen, Krankenhausstrasse 12, 91054 Erlangen, Germany.
J Plast Reconstr Aesthet Surg. 2016 Apr;69(4):545-53. doi: 10.1016/j.bjps.2015.11.025. Epub 2015 Dec 17.
Free flap transplantation to vascular reconstructions as arteriovenous (AV) loops has been established in centers as a feasible therapeutic option for defect reconstruction in the absence of proper recipient vessels, caused by oncologic resections, radiation, or trauma. We report our 10-year experience in free flap transplantation after vascular reconstruction with special emphasis on complication rate and postoperative mobility.
Forty-seven patients (mean age: 60 years, range: 19-86) were included. Defect etiology was posttraumatic in 19 patients; 14 defects were due to oncological resections and seven sternal osteomyelitis; three patients presented with radiation ulcers, two with aseptic femoral head necrosis, and one with defects caused by acne inversa and hip joint prosthesis infection. Long-term follow-up was 45 months (range: 0-126). We performed arterial revascularization with 36 AV loops, eight bypass grafts, and three venous interposition grafts. Subsequent tissue transfer comprised 24 latissimus dorsi, two vastus lateralis, one gracilis, one anterior lateral thigh (ALT), 16 rectus abdominis, one radialis forearm, and two osteocutaneous vascularized fibula flaps.
Complications occurred in 25/47 patients (53%). Early complications included five acute occlusions of arterial reconstructions and six major bleedings. There were six flap losses and three major amputations. Two in-hospital deaths were observed (4%). Overall survival accounted for 89.0 and 74.7% after 1 and 5 years, respectively.
The 5-year survival rate in long-term follow-up is favorable, despite an initially elevated complication rate. Successful defect coverage can be achieved by this method in a high percentage of patients.
在一些中心,游离皮瓣移植作为动静脉(AV)袢用于血管重建已成为一种可行的治疗选择,可用于因肿瘤切除、放疗或创伤导致缺乏合适受区血管时的缺损重建。我们报告了我们在血管重建后游离皮瓣移植的10年经验,特别强调并发症发生率和术后活动能力。
纳入47例患者(平均年龄:60岁,范围:19 - 86岁)。缺损病因方面,19例为创伤后;14例缺损是由于肿瘤切除,7例为胸骨骨髓炎;3例患者有放射性溃疡,2例有无菌性股骨头坏死,1例有化脓性汗腺炎和髋关节假体感染导致的缺损。长期随访时间为45个月(范围:0 - 126个月)。我们进行了36个AV袢的动脉血运重建、8个搭桥移植和3个静脉移植。随后的组织移植包括24个背阔肌、2个股外侧肌、1个股薄肌、1个股前外侧(ALT)、16个腹直肌、1个桡侧前臂皮瓣和2个带血管蒂的腓骨骨皮瓣。
47例患者中有25例(53%)发生并发症。早期并发症包括5例动脉重建急性闭塞和6例大出血。有6例皮瓣丢失和3例大截肢。观察到2例住院死亡(4%)。1年和5年后的总生存率分别为89.0%和74.7%。
尽管最初并发症发生率较高,但长期随访的5年生存率良好。通过这种方法,在高比例的患者中可以成功实现缺损覆盖。